Plasma homocysteine and cardiovascular disease mortality

Lancet

Volumn 349, Issue 9049, 1997, Pages 397-

  Alfthan, Georg ^a   Aro, Antti ^b   Gey, K Fred ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

AMINO ACID BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; HOMOCYSTINURIA; HUMAN; HUMAN TISSUE; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 0342437489     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)80014-1     Document Type: Article

References (5)

1. Malinow MR. Plasma homocyst(e)ine: a risk factor for arterial occlusive disease. J Nutr 1996; 126 (suppl 4): 1238-43S.
2. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma and serum: methods and clinical applications. Clin Chem 1993; 39: 1764-79.
3. Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988; 41: 155-78.
4. Kang SS, Wong PWK, Malinow MR. Hyperhomocysteinemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992; 12: 279-98.
5. Stamler JS, Slivka A. Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr Rev 1996; 54: 1-30.